Baird Initiates Coverage On Chimerix with Outperform Rating, Announces Price Target of $7
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Joel Beatty has initiated coverage on Chimerix (NASDAQ:CMRX) with an Outperform rating and a price target of $7.
May 23, 2023 | 8:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chimerix receives an Outperform rating and a $7 price target from Baird analyst Joel Beatty.
The initiation of coverage by Baird with an Outperform rating and a price target of $7 indicates a positive outlook for Chimerix. This news is likely to have a positive impact on the stock price in the short term as it reflects the analyst's confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100